Data represented as mean s.e.m., ns, not significant
Scientific References: Marathe CS, Rayner CK, Jones KL, Horowitz M
IGF-1 LR3 falls under the World Anti-Doping Agency's S2 category (peptide hormones, growth factors, related substances, and mimetics) and is prohibited at all times both in and out of competition
USA 103 , 79017905 (2006)
Read more on MIMS Pharma To view or add a comment, sign in Overview of GLP-1 Analogue Drugs: Brands, Companies & Clinical Uses GLP-1 analogues have transformed the treatment landscape for Type 2 Diabetes and obesity management offering better glycemic control, cardiovascular benefits, and effective weight loss
The developer provided this information and may update it over time